Healio

FDA approves once-weekly basal insulin for adults with type 2 diabetes

The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)

Teva’s biosimilar, PONLIMSI™, is now FDA-approved across all indications of the reference product, Prolia ® (denosumab), to treat a variety of ...

Greater weight loss promised by higher-dose Wegovy shot, now approved by FDA

The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight ...

The FDA just approved triple the previous maximum dose of Wegovy

The U.S. Food and Drug Administration has approved a new dose of the GLP-1 class weight loss drug Wegovy that’s three times the size of the previous maximum dose. Known as “We ...
The Barre-Montpelier Times Argus

Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers

Hims & Hers Health, Inc. (NYSE: HIMS) today announced that a broad assortment of Novo Nordisk’s FDA-approved GLP-1 ...

Navigating cGMP Compliance: Your 2026 Roadmap for Dietary Supplement and Cosmetic Manufacturers

Step-by-step guidance outlines the five core cGMP quality components, key FDA identity tests, and preparation for 2026 ...